Based on our experience, each new investigator requires approximately $1.5 million to establish an independent research program and obtain external support over an initial three-year period. The Institute guarantees to support the research programs of new investigators until they achieve independent support. We encourage new investigators to recruit postdoctoral fellows or graduate students, who are usually supported by Institute funds pending receipt of individual fellowships or other support. During the past five years (2003-2007) The Salk Institute invested more than $6.5 million (not including developmental funds from the CCSG) to establish the research programs of new investigators in the Cancer Center. (This amount does not include additional startup funds committed but not yet expended by recent appointees.) Support from CCSG developmental funds, although it was only a portion of the total required, was crucial in helping new appointees during the current funding period to establish and develop their independent research programs quickly and effectively. We anticipate that we will recruit one or two new investigators per year into the Cancer Center (this has been the average for the past several years). If each investigator requires two years to achieve independent funding, up to four investigators will require developmental support each year. We request funds to provide partial support for two investigators per year from the CCSG. As a result of an extensive review of Institute research programs over the past two years, several areas have been identified as high priorities for new faculty recruitment: biophotonics (advanced imaging), innate immunity, stem cell biology, metabolism, and inflammation biology. These areas will broaden and strengthen our cancer research program. We anticipate that two to three new faculty appointments will be made in each of these areas over the next several years, and that most of these new faculty members will become members of the Cancer Center.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Salk Institute for Biological Studies
La Jolla
United States
Zip Code
Aslanian, Aaron; Yates 3rd, John R; Hunter, Tony (2014) Mass spectrometry-based quantification of the cellular response to methyl methanesulfonate treatment in human cells. DNA Repair (Amst) 15:29-38
Lew, Erin D; Oh, Jennifer; Burrola, Patrick G et al. (2014) Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities. Elife 3:
Chaix, Amandine; Zarrinpar, Amir; Miu, Phuong et al. (2014) Time-restricted feeding is a preventative and therapeutic intervention against diverse nutritional challenges. Cell Metab 20:991-1005
Xia, Yifeng; Shen, Shen; Verma, Inder M (2014) NF-?B, an active player in human cancers. Cancer Immunol Res 2:823-30
Islam, Md Soriful; Catherino, William H; Protic, Olga et al. (2014) Role of activin-A and myostatin and their signaling pathway in human myometrial and leiomyoma cell function. J Clin Endocrinol Metab 99:E775-85
Evans, Ronald M; Mangelsdorf, David J (2014) Nuclear Receptors, RXR, and the Big Bang. Cell 157:255-66
Liu, Guang-Hui; Suzuki, Keiichiro; Li, Mo et al. (2014) Modelling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCs. Nat Commun 5:4330
Buchwalter, Abigail L; Liang, Yun; Hetzer, Martin W (2014) Nup50 is required for cell differentiation and exhibits transcription-dependent dynamics. Mol Biol Cell 25:2472-84
Hatori, Megumi; Gill, Shubhroz; Mure, Ludovic S et al. (2014) Lhx1 maintains synchrony among circadian oscillator neurons of the SCN. Elife 3:e03357
Korf, Katharina; Wodrich, Harald; Haschke, Alexander et al. (2014) The PML domain of PML-RAR? blocks senescence to promote leukemia. Proc Natl Acad Sci U S A 111:12133-8

Showing the most recent 10 out of 105 publications